1. Home
  2. EDU vs CAI Comparison

EDU vs CAI Comparison

Compare EDU & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Oriental Education & Technology Group Inc.

EDU

New Oriental Education & Technology Group Inc.

HOLD

Current Price

$57.54

Market Cap

9.0B

Sector

Real Estate

ML Signal

HOLD

CAI

Caris Life Sciences Inc.

N/A

Current Price

$24.93

Market Cap

8.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDU
CAI
Founded
1993
2008
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.0B
IPO Year
2006
2025

Fundamental Metrics

Financial Performance
Metric
EDU
CAI
Price
$57.54
$24.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$62.80
$34.71
AVG Volume (30 Days)
659.2K
2.2M
Earning Date
01-28-2026
02-12-2026
Dividend Yield
2.08%
N/A
EPS Growth
N/A
N/A
EPS
2.27
N/A
Revenue
$4,987,826,000.00
$649,062,000.00
Revenue This Year
$10.91
$77.47
Revenue Next Year
$10.38
$35.87
P/E Ratio
$25.46
N/A
Revenue Growth
7.29
112.02
52 Week Low
$40.66
$22.86
52 Week High
$61.56
$42.50

Technical Indicators

Market Signals
Indicator
EDU
CAI
Relative Strength Index (RSI) 56.27 N/A
Support Level $53.80 N/A
Resistance Level $60.06 N/A
Average True Range (ATR) 1.36 0.00
MACD -0.20 0.00
Stochastic Oscillator 59.42 0.00

Price Performance

Historical Comparison
EDU
CAI

About EDU New Oriental Education & Technology Group Inc.

New Oriental Education & Technology is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation and consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: